[Skip to Content]
[Skip to Content Landing]
Article
May 1985

Role of Débridement and Trifluridine (Trifluorothymidine) in Herpes Simplex Dendritic Keratitis

Author Affiliations

From the Cornea Service, Wills Eye Hospital, Philadelphia.

Arch Ophthalmol. 1985;103(5):673-675. doi:10.1001/archopht.1985.01050050065019
Abstract

• Thirty-four patients with herpes simplex dendritic keratitis were randomized into three treatment categories: Group A had débridement alone; group B, trifluridine (trifluorothymidine) alone; and group C, débridement and trifluridine. Patients treated with débridement alone had a statistically higher failure rate than did the other two groups. No statistically significant difference was observed between trifluridine treatment alone and débridement combined with trifluridine treatment, with regard to healing time. Our results suggest that débridement alone is suboptimal therapy for herpes simplex dendritic keratitis and that débridement combined with trifluridine appears to offer no advantage over trifluridine alone.

×